Paloma Geijo
38  results:
Search for persons X
?
3

Final Cox model for two-drug combinations versus triple the..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/journal_contribution/Final_Cox_model_for_two-drug_combinations_versus_triple_therapy_switch_due_to_toxicity_by_sub-analysis_/14389743.  , 2021
 
?
4

Status at end of observation period, overall sample, by tre..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Status_at_end_of_observation_period_overall_sample_by_treatment_group_/14389761.  , 2021
 
?
5

Antiretroviral therapy distribution within dolutegravir con..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Antiretroviral_therapy_distribution_within_dolutegravir_containing_therapy_sub-sample_by_treatment_group_/14389767.  , 2021
 
?
6

Patient-regimen end of the observation period status, by su..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/journal_contribution/Patient-regimen_end_of_the_observation_period_status_by_sub-analysis_and_treatment_group_/14389731.  , 2021
 
?
7

Antiretroviral therapy distribution, overall sample, by the..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Antiretroviral_therapy_distribution_overall_sample_by_therapy_group_/14389755.  , 2021
 
?
8

Sociodemographic and clinical characteristics at baseline, ..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/journal_contribution/Sociodemographic_and_clinical_characteristics_at_baseline_by_sub-analysis_and_treatment_group_/14389728.  , 2021
 
?
9

Kaplan-Meier curve for two-drug combinations versus triple ..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/figure/Kaplan-Meier_curve_for_two-drug_combinations_versus_triple_therapy_a_time_to_discontinuation_b_switch_due_to_virologic_failure_c_switch_due_to_toxicity_/14389746.  , 2021
 
?
10

Antiretroviral therapy distribution within suppressed at ba..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Antiretroviral_therapy_distribution_within_suppressed_at_baseline_sub-sample_by_treatment_group_/14389770.  , 2021
 
?
11

Final Cox model for two-drug combinations versus triple the..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Final_Cox_model_for_two-drug_combinations_versus_triple_therapy_time_to_discontinuation_switch_due_to_virologic_failure_and_switch_due_to_toxicity_overall_sample_/14389764.  , 2021
 
?
12

Adjusted hazard ratio for two-drug combinations versus trip..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/figure/Adjusted_hazard_ratio_for_two-drug_combinations_versus_triple_therapy_forest_plot_by_sample_and_endpoint_/14389752.  , 2021
 
?
13

Final Cox model for two-drug combinations versus triple the..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/journal_contribution/Final_Cox_model_for_two-drug_combinations_versus_triple_therapy_switch_due_to_virologic_failure_by_sub-analysis_/14389740.  , 2021
 
?
14

Final Cox model for two-drug combinations versus triple the..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/journal_contribution/Final_Cox_model_for_two-drug_combinations_versus_triple_therapy_time_to_discontinuation_by_sub-analysis_/14389737.  , 2021
 
?
15

Sociodemographic and clinical characteristics at baseline, ..:

Ramón Teira (10573722) ; Helena Diaz-Cuervo (7827890) ; Filipa Aragão (307309)...
https://figshare.com/articles/dataset/Sociodemographic_and_clinical_characteristics_at_baseline_overall_sample_/14389758.  , 2021
 
1-15